Biotech Industry Trends and Shared Lab Models — PharmaVoice

PharmaVoice explored how managed laboratory infrastructure is becoming central to modern drug development. I spoke about the need to align physical space, data systems, and operational expertise under one roof — reducing overhead while accelerating experimentation.

This piece placed our work within a broader movement toward modular, service-oriented R&D environments that would later define SmartLabs’ national platform.

Read the full article → PharmaVoice

Previous
Previous

Maximizing Discovery & Innovation While Minimizing Cost — Contract Pharma

Next
Next

Mass Innovation Labs is now SmartLabs — GlobeNewswire